本页面由Tiger Trade Technology Pte. Ltd.提供服务

Edesa Biotech

2.94
-0.5700-16.24%
盘后:2.940.00000.00%19:30 EDT
成交量:8.16万
成交额:25.67万
市值:3,972.38万
市盈率:-1.70
高:3.56
开:3.56
低:2.87
收:3.51
52周最高:20.32
52周最低:0.7200
股本:1,351.15万
流通股本:1,142.32万
量比:2.13
换手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):-1.7319
每股收益(LYR):-1.2658
净资产收益率:-122.93%
总资产收益率:-66.43%
市净率:99.56
市盈率(LYR):-2.32

数据加载中...

2026/08/27

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/20

重要事件披露

Form 8-K - Current report
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/06/18

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/13

重要事件披露

Form 8-K - Current report
2026/02/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]